Endo International can’t stop Vasostrict generic

02-09-2021

Alex Baldwin

Endo International can’t stop Vasostrict generic

rafapress / Shutterstock.com

The US District Court for the District of Delaware has ruled that one of Endo International’s pharma units cannot stop a generic of its blood pressure drug Vasostrict (vasopressin injection) from being made.


The US District Court for the District of Delaware, Endo International, Vasosctrict, Par Pharmaceuticals, Eagle Pharmaceuticals, Colm Connolly

LSIPR